News
TipRanks on MSN11h
Purple Biotech Secures European Patent for NT219 Combinations
An update from Purple Biotech ( ($PPBT) ) is now available. On September 10, 2025, Purple Biotech announced that the European Patent Office ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
TipRanks on MSN6d
Purple Biotech Unveils Promising Data on CAPTN-3 Antibody Design
Purple Biotech ( ($PPBT) ) has provided an announcement. On September 4, 2025, Purple Biotech announced new data supporting the unique design of ...
Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing ...
1 Day PPBT 2.26% DJIA -0.14% Russell 2K 0.60% Health Care/Life Sciences -0.79% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback